Mölndal, Sweden

Lena Elisabeth Ripa



 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Lund, SE (2010 - 2011)
  • Mölndal, SE (2018 - 2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Lena Elisabeth Ripa

Introduction

Lena Elisabeth Ripa, a talented inventor based in Mölndal, Sweden, has made significant contributions to the field of medicinal chemistry with a focus on pharmaceutical compounds. With a total of six patents to her name, she has dedicated her expertise to developing innovative solutions for various health challenges.

Latest Patents

One of Lena's latest patents involves novel chemical compounds intended for the treatment of diseases mediated by the epithelial sodium channel (ENaC), such as asthma, cystic fibrosis (CF), and chronic obstructive pulmonary disease (COPD). This invention provides a compound of a specific formula and includes a process for preparing such a compound, as well as its applications in therapeutics.

Career Highlights

Lena Elisabeth Ripa is associated with AstraZeneca AB, a global biopharmaceutical company known for its focus on innovation in drug discovery and development. Her work at AstraZeneca has positioned her as a key player in advancing therapeutic alternatives for patients suffering from respiratory diseases.

Collaborations

Throughout her career, Lena has collaborated with esteemed colleagues such as Martin Hemmerling and Susanne Elisabeth Berglund. Their combined expertise has led to a vibrant research environment, fostering innovations that aim to enhance patient outcomes.

Conclusion

Lena Elisabeth Ripa continues to pave the way for advancements in pharmaceutical science. With her groundbreaking patents and collaborative efforts, she is making a positive impact on the healthcare landscape, underlining the importance of innovation in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…